English
简体中文
Total: £ 56.28
Published Date: 2026-02-06 | Pages: 133 | Tables: 137 | Medical Devices & Consumables
The global Lower Extremity Exoskeleton Enhancement Device market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Lower Extremity Exoskeleton Enhancement Device competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Lower extremity exoskeleton enhancement device, also known as lower extremity exoskeleton robot, is an intelligent auxiliary bone system based on bionics and ergonomic design, and has the end traction type rehabilitation robot, through the coexistence of robot technology and human body interaction to achieve human body strengthening, collaborative movement and rehabilitation treatment and other functions.
The North American market for Lower Extremity Exoskeleton Enhancement Device is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Lower Extremity Exoskeleton Enhancement Device is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Lower Extremity Exoskeleton Enhancement Device include Cyberdyne, Hocoma, ReWalk Robotics, Ekso Bionics, LockHeed Martin, Parker Hannifin, Interactive Motion Technologies, Panasonic, Myomo, B-TEMIA Inc., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Lower Extremity Exoskeleton Enhancement Device market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Lower Extremity Exoskeleton Enhancement Device. The Lower Extremity Exoskeleton Enhancement Device market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Lower Extremity Exoskeleton Enhancement Device market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Lower Extremity Exoskeleton Enhancement Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Cyberdyne
Hocoma
ReWalk Robotics
Ekso Bionics
LockHeed Martin
Parker Hannifin
Interactive Motion Technologies
Panasonic
Myomo
B-TEMIA Inc.
Alter G
US Bionics
Siyi Intelligence
Pharos Medical Technology
Shenzhen Ruihan Medical Technology
Mile Bot
Segment by Type
Smart Type
Conventional Type
by Application
Recovery Treatment
Industrial
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Lower Extremity Exoskeleton Enhancement Device manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Lower Extremity Exoskeleton Enhancement Device sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Lower Extremity Exoskeleton Enhancement Device Market Overview
1.1 Product Definition
1.2 Lower Extremity Exoskeleton Enhancement Device by Type
1.2.1 Global Lower Extremity Exoskeleton Enhancement Device Market Value by Type: 2025 vs 2032
1.2.2 Smart Type
1.2.3 Conventional Type
1.3 Lower Extremity Exoskeleton Enhancement Device by Application
1.3.1 Global Lower Extremity Exoskeleton Enhancement Device Market Value by Application: 2025 vs 2032
1.3.2 Recovery Treatment
1.3.3 Industrial
1.3.4 Others
1.4 Global Lower Extremity Exoskeleton Enhancement Device Market Size Estimates and Forecasts
1.4.1 Global Lower Extremity Exoskeleton Enhancement Device Revenue 2021–2032
1.4.2 Global Lower Extremity Exoskeleton Enhancement Device Sales 2021–2032
1.4.3 Global Lower Extremity Exoskeleton Enhancement Device Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Lower Extremity Exoskeleton Enhancement Device Market Competition by Manufacturers
2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Manufacturers (2021–2026)
2.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Lower Extremity Exoskeleton Enhancement Device Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Lower Extremity Exoskeleton Enhancement Device, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Lower Extremity Exoskeleton Enhancement Device, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Lower Extremity Exoskeleton Enhancement Device, Product Types and Applications
2.7 Global Key Manufacturers of Lower Extremity Exoskeleton Enhancement Device, Date of Entry into the Industry
2.8 Global Lower Extremity Exoskeleton Enhancement Device Market Competitive Situation and Trends
2.8.1 Global Lower Extremity Exoskeleton Enhancement Device Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Lower Extremity Exoskeleton Enhancement Device Players Market Share by Revenue
2.8.3 Global Lower Extremity Exoskeleton Enhancement Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Lower Extremity Exoskeleton Enhancement Device Market Scenario by Region
3.1 Global Lower Extremity Exoskeleton Enhancement Device Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region: 2021–2032
3.2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region: 2021–2026
3.2.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region: 2027–2032
3.3 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region: 2021–2032
3.3.1 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region: 2021–2026
3.3.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region: 2027–2032
3.4 North America Lower Extremity Exoskeleton Enhancement Device Market Facts & Figures by Country
3.4.1 North America Lower Extremity Exoskeleton Enhancement Device Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021–2032)
3.4.3 North America Lower Extremity Exoskeleton Enhancement Device Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lower Extremity Exoskeleton Enhancement Device Market Facts & Figures by Country
3.5.1 Europe Lower Extremity Exoskeleton Enhancement Device Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021–2032)
3.5.3 Europe Lower Extremity Exoskeleton Enhancement Device Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lower Extremity Exoskeleton Enhancement Device Market Facts & Figures by Region
3.6.1 Asia Pacific Lower Extremity Exoskeleton Enhancement Device Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Lower Extremity Exoskeleton Enhancement Device Sales by Region (2021–2032)
3.6.3 Asia Pacific Lower Extremity Exoskeleton Enhancement Device Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Lower Extremity Exoskeleton Enhancement Device Market Facts & Figures by Country
3.7.1 Latin America Lower Extremity Exoskeleton Enhancement Device Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021–2032)
3.7.3 Latin America Lower Extremity Exoskeleton Enhancement Device Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021–2032)
3.8.3 Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021–2032)
4.1.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021–2026)
4.1.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2027–2032)
4.1.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Type (2021–2032)
4.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021–2032)
4.2.1 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021–2026)
4.2.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2027–2032)
4.2.3 Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Type (2021–2032)
4.3 Global Lower Extremity Exoskeleton Enhancement Device Price by Type (2021–2032)
5 Segment by Application
5.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021–2032)
5.1.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021–2026)
5.1.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2027–2032)
5.1.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Application (2021–2032)
5.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021–2032)
5.2.1 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021–2026)
5.2.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2027–2032)
5.2.3 Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Application (2021–2032)
5.3 Global Lower Extremity Exoskeleton Enhancement Device Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Cyberdyne
6.1.1 Cyberdyne Company Information
6.1.2 Cyberdyne Description and Business Overview
6.1.3 Cyberdyne Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Cyberdyne Lower Extremity Exoskeleton Enhancement Device Product Portfolio
6.1.5 Cyberdyne Recent Developments/Updates
6.2 Hocoma
6.2.1 Hocoma Company Information
6.2.2 Hocoma Description and Business Overview
6.2.3 Hocoma Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Hocoma Lower Extremity Exoskeleton Enhancement Device Product Portfolio
6.2.5 Hocoma Recent Developments/Updates
6.3 ReWalk Robotics
6.3.1 ReWalk Robotics Company Information
6.3.2 ReWalk Robotics Description and Business Overview
6.3.3 ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
6.3.5 ReWalk Robotics Recent Developments/Updates
6.4 Ekso Bionics
6.4.1 Ekso Bionics Company Information
6.4.2 Ekso Bionics Description and Business Overview
6.4.3 Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
6.4.5 Ekso Bionics Recent Developments/Updates
6.5 LockHeed Martin
6.5.1 LockHeed Martin Company Information
6.5.2 LockHeed Martin Description and Business Overview
6.5.3 LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Product Portfolio
6.5.5 LockHeed Martin Recent Developments/Updates
6.6 Parker Hannifin
6.6.1 Parker Hannifin Company Information
6.6.2 Parker Hannifin Description and Business Overview
6.6.3 Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Product Portfolio
6.6.5 Parker Hannifin Recent Developments/Updates
6.7 Interactive Motion Technologies
6.7.1 Interactive Motion Technologies Company Information
6.7.2 Interactive Motion Technologies Description and Business Overview
6.7.3 Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Product Portfolio
6.7.5 Interactive Motion Technologies Recent Developments/Updates
6.8 Panasonic
6.8.1 Panasonic Company Information
6.8.2 Panasonic Description and Business Overview
6.8.3 Panasonic Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Panasonic Lower Extremity Exoskeleton Enhancement Device Product Portfolio
6.8.5 Panasonic Recent Developments/Updates
6.9 Myomo
6.9.1 Myomo Company Information
6.9.2 Myomo Description and Business Overview
6.9.3 Myomo Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Myomo Lower Extremity Exoskeleton Enhancement Device Product Portfolio
6.9.5 Myomo Recent Developments/Updates
6.10 B-TEMIA Inc.
6.10.1 B-TEMIA Inc. Company Information
6.10.2 B-TEMIA Inc. Description and Business Overview
6.10.3 B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Product Portfolio
6.10.5 B-TEMIA Inc. Recent Developments/Updates
6.11 Alter G
6.11.1 Alter G Company Information
6.11.2 Alter G Description and Business Overview
6.11.3 Alter G Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Alter G Lower Extremity Exoskeleton Enhancement Device Product Portfolio
6.11.5 Alter G Recent Developments/Updates
6.12 US Bionics
6.12.1 US Bionics Company Information
6.12.2 US Bionics Description and Business Overview
6.12.3 US Bionics Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 US Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
6.12.5 US Bionics Recent Developments/Updates
6.13 Siyi Intelligence
6.13.1 Siyi Intelligence Company Information
6.13.2 Siyi Intelligence Description and Business Overview
6.13.3 Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Product Portfolio
6.13.5 Siyi Intelligence Recent Developments/Updates
6.14 Pharos Medical Technology
6.14.1 Pharos Medical Technology Company Information
6.14.2 Pharos Medical Technology Description and Business Overview
6.14.3 Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio
6.14.5 Pharos Medical Technology Recent Developments/Updates
6.15 Shenzhen Ruihan Medical Technology
6.15.1 Shenzhen Ruihan Medical Technology Company Information
6.15.2 Shenzhen Ruihan Medical Technology Description and Business Overview
6.15.3 Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio
6.15.5 Shenzhen Ruihan Medical Technology Recent Developments/Updates
6.16 Mile Bot
6.16.1 Mile Bot Company Information
6.16.2 Mile Bot Description and Business Overview
6.16.3 Mile Bot Lower Extremity Exoskeleton Enhancement Device Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Mile Bot Lower Extremity Exoskeleton Enhancement Device Product Portfolio
6.16.5 Mile Bot Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lower Extremity Exoskeleton Enhancement Device Industry Chain Analysis
7.2 Lower Extremity Exoskeleton Enhancement Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lower Extremity Exoskeleton Enhancement Device Production Mode & Process Analysis
7.4 Lower Extremity Exoskeleton Enhancement Device Sales and Marketing
7.4.1 Lower Extremity Exoskeleton Enhancement Device Sales Channels
7.4.2 Lower Extremity Exoskeleton Enhancement Device Distributors
7.5 Lower Extremity Exoskeleton Enhancement Device Customer Analysis
8 Lower Extremity Exoskeleton Enhancement Device Market Dynamics
8.1 Lower Extremity Exoskeleton Enhancement Device Industry Trends
8.2 Lower Extremity Exoskeleton Enhancement Device Market Drivers
8.3 Lower Extremity Exoskeleton Enhancement Device Market Challenges
8.4 Lower Extremity Exoskeleton Enhancement Device Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Lower Extremity Exoskeleton Enhancement Device Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Lower Extremity Exoskeleton Enhancement Device Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Lower Extremity Exoskeleton Enhancement Device Market Competitive Situation by Manufacturers in 2025
Table 4. Global Lower Extremity Exoskeleton Enhancement Device Sales (Units) of Key Manufacturers (2021–2026)
Table 5. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Lower Extremity Exoskeleton Enhancement Device Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Lower Extremity Exoskeleton Enhancement Device Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Lower Extremity Exoskeleton Enhancement Device Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Lower Extremity Exoskeleton Enhancement Device, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Lower Extremity Exoskeleton Enhancement Device, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Lower Extremity Exoskeleton Enhancement Device, Product Types and Applications
Table 12. Global Key Manufacturers of Lower Extremity Exoskeleton Enhancement Device, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lower Extremity Exoskeleton Enhancement Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on Lower Extremity Exoskeleton Enhancement Device Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Lower Extremity Exoskeleton Enhancement Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (Units), 2021–2026
Table 18. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Region (2021–2026)
Table 19. Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (Units), 2027–2032
Table 20. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Region (2027–2032)
Table 21. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region (US$ Million), 2021–2026
Table 22. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Region (2021–2026)
Table 23. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region (US$ Million), 2027–2032
Table 24. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Region (2027–2032)
Table 25. North America Lower Extremity Exoskeleton Enhancement Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Lower Extremity Exoskeleton Enhancement Device Sales by Country (Units), 2021–2026
Table 27. North America Lower Extremity Exoskeleton Enhancement Device Sales by Country (Units), 2027–2032
Table 28. North America Lower Extremity Exoskeleton Enhancement Device Revenue by Country (US$ Million), 2021–2026
Table 29. North America Lower Extremity Exoskeleton Enhancement Device Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Lower Extremity Exoskeleton Enhancement Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Lower Extremity Exoskeleton Enhancement Device Sales by Country (Units), 2021–2026
Table 32. Europe Lower Extremity Exoskeleton Enhancement Device Sales by Country (Units), 2027–2032
Table 33. Europe Lower Extremity Exoskeleton Enhancement Device Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Lower Extremity Exoskeleton Enhancement Device Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Sales by Region (Units), 2021–2026
Table 37. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Sales by Region (Units), 2027–2032
Table 38. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Lower Extremity Exoskeleton Enhancement Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Lower Extremity Exoskeleton Enhancement Device Sales by Country (Units), 2021–2026
Table 42. Latin America Lower Extremity Exoskeleton Enhancement Device Sales by Country (Units), 2027–2032
Table 43. Latin America Lower Extremity Exoskeleton Enhancement Device Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Lower Extremity Exoskeleton Enhancement Device Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales by Country (Units), 2021–2026
Table 47. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales by Country (Units), 2027–2032
Table 48. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Revenue by Country (US$ Million), 2027–2032
Table 50. Global Lower Extremity Exoskeleton Enhancement Device Sales (Units) by Type (2021–2026)
Table 51. Global Lower Extremity Exoskeleton Enhancement Device Sales (Units) by Type (2027–2032)
Table 52. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Type (2021–2026)
Table 53. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Type (2027–2032)
Table 54. Global Lower Extremity Exoskeleton Enhancement Device Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Lower Extremity Exoskeleton Enhancement Device Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Type (2021–2026)
Table 57. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Type (2027–2032)
Table 58. Global Lower Extremity Exoskeleton Enhancement Device Price (US$/Unit) by Type (2021–2026)
Table 59. Global Lower Extremity Exoskeleton Enhancement Device Price (US$/Unit) by Type (2027–2032)
Table 60. Global Lower Extremity Exoskeleton Enhancement Device Sales (Units) by Application (2021–2026)
Table 61. Global Lower Extremity Exoskeleton Enhancement Device Sales (Units) by Application (2027–2032)
Table 62. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Application (2021–2026)
Table 63. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Application (2027–2032)
Table 64. Global Lower Extremity Exoskeleton Enhancement Device Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Lower Extremity Exoskeleton Enhancement Device Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Application (2021–2026)
Table 67. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Application (2027–2032)
Table 68. Global Lower Extremity Exoskeleton Enhancement Device Price (US$/Unit) by Application (2021–2026)
Table 69. Global Lower Extremity Exoskeleton Enhancement Device Price (US$/Unit) by Application (2027–2032)
Table 70. Cyberdyne Company Information
Table 71. Cyberdyne Description and Business Overview
Table 72. Cyberdyne Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Cyberdyne Lower Extremity Exoskeleton Enhancement Device Product
Table 74. Cyberdyne Recent Developments/Updates
Table 75. Hocoma Company Information
Table 76. Hocoma Description and Business Overview
Table 77. Hocoma Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Hocoma Lower Extremity Exoskeleton Enhancement Device Product
Table 79. Hocoma Recent Developments/Updates
Table 80. ReWalk Robotics Company Information
Table 81. ReWalk Robotics Description and Business Overview
Table 82. ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Product
Table 84. ReWalk Robotics Recent Developments/Updates
Table 85. Ekso Bionics Company Information
Table 86. Ekso Bionics Description and Business Overview
Table 87. Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Product
Table 89. Ekso Bionics Recent Developments/Updates
Table 90. LockHeed Martin Company Information
Table 91. LockHeed Martin Description and Business Overview
Table 92. LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Product
Table 94. LockHeed Martin Recent Developments/Updates
Table 95. Parker Hannifin Company Information
Table 96. Parker Hannifin Description and Business Overview
Table 97. Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Product
Table 99. Parker Hannifin Recent Developments/Updates
Table 100. Interactive Motion Technologies Company Information
Table 101. Interactive Motion Technologies Description and Business Overview
Table 102. Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Product
Table 104. Interactive Motion Technologies Recent Developments/Updates
Table 105. Panasonic Company Information
Table 106. Panasonic Description and Business Overview
Table 107. Panasonic Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Panasonic Lower Extremity Exoskeleton Enhancement Device Product
Table 109. Panasonic Recent Developments/Updates
Table 110. Myomo Company Information
Table 111. Myomo Description and Business Overview
Table 112. Myomo Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Myomo Lower Extremity Exoskeleton Enhancement Device Product
Table 114. Myomo Recent Developments/Updates
Table 115. B-TEMIA Inc. Company Information
Table 116. B-TEMIA Inc. Description and Business Overview
Table 117. B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Product
Table 119. B-TEMIA Inc. Recent Developments/Updates
Table 120. Alter G Company Information
Table 121. Alter G Description and Business Overview
Table 122. Alter G Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Alter G Lower Extremity Exoskeleton Enhancement Device Product
Table 124. Alter G Recent Developments/Updates
Table 125. US Bionics Company Information
Table 126. US Bionics Description and Business Overview
Table 127. US Bionics Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. US Bionics Lower Extremity Exoskeleton Enhancement Device Product
Table 129. US Bionics Recent Developments/Updates
Table 130. Siyi Intelligence Company Information
Table 131. Siyi Intelligence Description and Business Overview
Table 132. Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Product
Table 134. Siyi Intelligence Recent Developments/Updates
Table 135. Pharos Medical Technology Company Information
Table 136. Pharos Medical Technology Description and Business Overview
Table 137. Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Product
Table 139. Pharos Medical Technology Recent Developments/Updates
Table 140. Shenzhen Ruihan Medical Technology Company Information
Table 141. Shenzhen Ruihan Medical Technology Description and Business Overview
Table 142. Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Product
Table 144. Shenzhen Ruihan Medical Technology Recent Developments/Updates
Table 145. Mile Bot Company Information
Table 146. Mile Bot Description and Business Overview
Table 147. Mile Bot Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Mile Bot Lower Extremity Exoskeleton Enhancement Device Product
Table 149. Mile Bot Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Lower Extremity Exoskeleton Enhancement Device Distributors List
Table 153. Lower Extremity Exoskeleton Enhancement Device Customers List
Table 154. Lower Extremity Exoskeleton Enhancement Device Market Trends
Table 155. Lower Extremity Exoskeleton Enhancement Device Market Drivers
Table 156. Lower Extremity Exoskeleton Enhancement Device Market Challenges
Table 157. Lower Extremity Exoskeleton Enhancement Device Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Lower Extremity Exoskeleton Enhancement Device
Figure 2. Global Lower Extremity Exoskeleton Enhancement Device Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Lower Extremity Exoskeleton Enhancement Device Market Share by Type: 2025 & 2032
Figure 4. Smart Type Product Picture
Figure 5. Conventional Type Product Picture
Figure 6. Global Lower Extremity Exoskeleton Enhancement Device Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Lower Extremity Exoskeleton Enhancement Device Market Share by Application: 2025 & 2032
Figure 8. Recovery Treatment
Figure 9. Industrial
Figure 10. Others
Figure 11. Global Lower Extremity Exoskeleton Enhancement Device Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Lower Extremity Exoskeleton Enhancement Device Market Size (US$ Million), 2021–2032
Figure 13. Global Lower Extremity Exoskeleton Enhancement Device Sales (Units), 2021–2032
Figure 14. Global Lower Extremity Exoskeleton Enhancement Device Average Price (US$/Unit), 2021–2032
Figure 15. Lower Extremity Exoskeleton Enhancement Device Report Years Considered
Figure 16. Lower Extremity Exoskeleton Enhancement Device Sales Share by Manufacturers in 2025
Figure 17. Global Lower Extremity Exoskeleton Enhancement Device Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Lower Extremity Exoskeleton Enhancement Device Players: Market Share by Revenue in Lower Extremity Exoskeleton Enhancement Device in 2025
Figure 19. Lower Extremity Exoskeleton Enhancement Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Lower Extremity Exoskeleton Enhancement Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2021–2032)
Figure 22. North America Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Country (2021–2032)
Figure 23. United States Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2021–2032)
Figure 26. Europe Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Country (2021–2032)
Figure 27. Germany Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Region (2021–2032)
Figure 34. China Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2021–2032)
Figure 42. Latin America Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Lower Extremity Exoskeleton Enhancement Device by Type (2021–2032)
Figure 53. Global Revenue Market Share of Lower Extremity Exoskeleton Enhancement Device by Type (2021–2032)
Figure 54. Global Lower Extremity Exoskeleton Enhancement Device Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Lower Extremity Exoskeleton Enhancement Device by Application (2021–2032)
Figure 56. Global Revenue Market Share of Lower Extremity Exoskeleton Enhancement Device by Application (2021–2032)
Figure 57. Global Lower Extremity Exoskeleton Enhancement Device Price (US$/Unit) by Application (2021–2032)
Figure 58. Lower Extremity Exoskeleton Enhancement Device Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
